Provided by Tiger Trade Technology Pte. Ltd.

Tempus AI

68.73
+2.563.87%
Post-market: 68.53-0.2000-0.29%17:28 EDT
Volume:8.86M
Turnover:605.57M
Market Cap:12.40B
PE:-47.94
High:70.79
Open:66.58
Low:63.61
Close:66.17
52wk High:104.32
52wk Low:40.77
Shares:180.43M
Float Shares:115.00M
Volume Ratio:0.60
T/O Rate:7.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4337
EPS(LYR):-1.4100
ROE:-67.44%
ROA:-8.55%
PB:27.87
PE(LYR):-48.74

Loading ...

tempus AI Inc Class A call volume above normal and directionally bullish

TIPRANKS
·
Jun 25

Tempus AI Launches Angiosarcoma Research Collaboration with Angiosarcoma Awareness

Reuters
·
Jun 25

Movement Alert|Tempus AI Rises 5.02% in Regular Trading, Trading at $51.31

Market Focus
·
Jun 24

Anthropic’S Mythos Model Uncovers US Intelligence Vulnerabilities Within Hours; Demonstrates Potent Cyber Defense And Offense Capabilities

AI Industry Frontlines
·
Jun 24

Movement Alert|Tempus AI Falls 5.02% in Regular Trading, Trading at $48.24

Market Focus
·
Jun 22

BofA Warns: AI Bubble Flashes Historic Danger Signals

AI Industry Frontlines
·
Jun 22

Can Tempus AI’s (TEM) New ECG-AF Validation Deepen Its Edge in Clinical-Grade Healthcare AI?

Simply Wall St.
·
Jun 21

Movement Alert|Tempus AI Rises 6.11% in Regular Trading, FDA Approval of xT CDx Platform and Technical Rebound Lift Sentiment

Market Focus
·
Jun 15

Tempus AI says multi-center study validates FDA-cleared ECG model predicting 1-year atrial fibrillation risk

Reuters
·
Jun 11

Movement Alert|Tempus AI Intraday Rise 5.07% in Regular Trading, FDA Approval of xT CDx Platform Combined with Oversold Rebound Lifts Sentiment

Market Focus
·
Jun 10

Movement Alert|Tempus AI Falls 5.47% in Regular Trading, Major Shareholder Continued Selling Pressures Market Sentiment

Market Focus
·
Jun 10

Tempus unit Ambry study finds ExomeReveal RNA testing boosts clarity for uncertain exome results

Reuters
·
Jun 09

If AI Healthcare Wins Big These Three Stocks Could Matter

Simply Wall St.
·
Jun 08

Skip the Oura Ring IPO. Buy These 10 Stocks Instead.

InvestorPlace
·
Jun 07

Is Tempus AI’s (TEM) New Oncology Tools Quietly Redefining Its Precision Medicine Moat?

Simply Wall St.
·
Jun 06

Movement Alert|Tempus AI Intraday Decline 5.34%, Major Shareholder Persistent Selling and Sector Weakness Extend Selling Pressure

Market Focus
·
Jun 05

Movement Alert|Tempus AI Rises 5.28% in Regular Trading, FDA Approval of xT CDx Platform and New AI Launch Continue to Drive Momentum

Market Focus
·
Jun 04

Tempus AI director David R. Epstein reports disposal of 250 common shares worth $12,350

Reuters
·
Jun 04

Tempus AI launches open-source digital pathology consortium

TIPRANKS
·
Jun 03

Movement Alert|Tempus AI Intraday Decline 5.48%, Major Shareholder Continued Selling Pressure Compounded by Sector-Wide Weakness

Market Focus
·
Jun 03